Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
复制标题

DOI:
10.1002/cpt.2149
复制
发表时间:
2021-10
影响因子:
6.7
通讯作者:
Skaar TC
Skaar TC
中科院分区:
医学2区
文献类型:
--
作者:
Crews KR;Monte AA;Huddart R;Caudle KE;Kharasch ED;Gaedigk A;Dunnenberger HM;Leeder JS;Callaghan JT;Samer CF;Klein TE;Haidar CE;Van Driest SL;Ruano G;Sangkuhl K;Cavallari LH;Müller DJ;Prows CA;Nagy M;Somogyi AA;Skaar TC

文献摘要

参考文献

被引文献

相似文献

阿片类药物主要用于治疗急性和慢性疼痛。几种阿片类药物在一定程度上通过CYP 2D 6代谢(可待因、曲马多、氢可酮、羟考酮和美沙酮)。已研究了CYP 2D 6的多态性与这些药物的临床效果和安全性的相关性。已经研究了与阿片类药物临床作用或不良事件相关的其他基因包括OPRM 1(μ受体)和COMT(儿茶酚-O-甲基转移酶)。本指南更新并扩展了2014年临床药物遗传学实施联盟(CPIC)关于CYP 2D 6基因型和可待因治疗的指南,并包括描述CYP 2D 6、OPRM 1和COMT对阿片类镇痛和不良事件影响的证据总结。我们提供了使用CYP 2D 6基因型结果处方可待因和曲马多的治疗建议,并描述了有限的和/或薄弱的数据CYP 2D 6和氢可酮,羟考酮和美沙酮和OPRM 1和COMT的临床使用。
Opioids are mainly used to treat both acute and chronic pain. Several opioids are metabolized to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone and methadone). Polymorphisms in CYP2D6 have been studied for an association with the clinical effect and safety of these drugs. Other genes which have been studied for their association with opioid clinical effect or adverse events include OPRM1 (mu receptor) and COMT (catechol-O-methyltransferase). This guideline updates and expands the 2014 Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and codeine therapy and includes a summation of the evidence describing the impact of CYP2D6, OPRM1 and COMT on opioid analgesia and adverse events. We provide therapeutic recommendations for the use of CYP2D6 genotype results for prescribing codeine and tramadol and describe the limited and/or weak data for CYP2D6 and hydrocodone, oxycodone and methadone and for OPRM1 and COMT for clinical use.
DOI: 10.1038/sj.tpj.6500406
发表时间: 2007-08-01
影响因子: 2.8
作者:
Kirchheiner, J.;Schmidt, H.;Brockmoeller, J.
通讯作者: Brockmoeller, J.
DOI: 10.1056/nejmoa041888
发表时间: 2004-12-30
影响因子: 158.5
作者:
Gasche, Y;Daali, Y;Desmeules, J
通讯作者: Desmeules, J
DOI: 10.1038/clpt.2013.254
发表时间: 2014-04-01
影响因子: 6.7
作者:
Crews, K. R.;Gaedigk, A.;Skaar, T. C.
通讯作者: Skaar, T. C.
DOI: 10.1007/s00228-011-1093-5
发表时间: 2012-01-01
影响因子: 2.9
作者:
Andreassen, Trine Naalsund;Eftedal, Ingrid;Dale, Ola
通讯作者: Dale, Ola
DOI: 10.1016/j.pain.2009.03.023
发表时间: 2009-07-01
期刊: PAIN
影响因子: 7.4
作者:
Loetsch, Joern;Rohrbacher, Maren;Geisslinger, Gerd
通讯作者: Geisslinger, Gerd